614 related articles for article (PubMed ID: 34075056)
1. Abnormal brain cholesterol homeostasis in Alzheimer's disease-a targeted metabolomic and transcriptomic study.
Varma VR; Büşra Lüleci H; Oommen AM; Varma S; Blackshear CT; Griswold ME; An Y; Roberts JA; O'Brien R; Pletnikova O; Troncoso JC; Bennett DA; Çakır T; Legido-Quigley C; Thambisetty M
NPJ Aging Mech Dis; 2021 Jun; 7(1):11. PubMed ID: 34075056
[TBL] [Abstract][Full Text] [Related]
2. Bile acid synthesis, modulation, and dementia: A metabolomic, transcriptomic, and pharmacoepidemiologic study.
Varma VR; Wang Y; An Y; Varma S; Bilgel M; Doshi J; Legido-Quigley C; Delgado JC; Oommen AM; Roberts JA; Wong DF; Davatzikos C; Resnick SM; Troncoso JC; Pletnikova O; O'Brien R; Hak E; Baak BN; Pfeiffer R; Baloni P; Mohmoudiandehkordi S; Nho K; Kaddurah-Daouk R; Bennett DA; Gadalla SM; Thambisetty M
PLoS Med; 2021 May; 18(5):e1003615. PubMed ID: 34043628
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
[TBL] [Abstract][Full Text] [Related]
4. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
[TBL] [Abstract][Full Text] [Related]
5. Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment.
Loera-Valencia R; Goikolea J; Parrado-Fernandez C; Merino-Serrais P; Maioli S
J Steroid Biochem Mol Biol; 2019 Jun; 190():104-114. PubMed ID: 30878503
[TBL] [Abstract][Full Text] [Related]
6. Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease.
Gosselet F; Saint-Pol J; Fenart L
Biochem Biophys Res Commun; 2014 Apr; 446(3):687-91. PubMed ID: 24275140
[TBL] [Abstract][Full Text] [Related]
7. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol Metabolism in the Brain and Its Association with Parkinson's Disease.
Jin U; Park SJ; Park SM
Exp Neurobiol; 2019 Oct; 28(5):554-567. PubMed ID: 31698548
[TBL] [Abstract][Full Text] [Related]
9. Novel therapeutic strategies for Alzheimer's disease targeting brain cholesterol homeostasis.
Samant NP; Gupta GL
Eur J Neurosci; 2021 Jan; 53(2):673-686. PubMed ID: 32852876
[TBL] [Abstract][Full Text] [Related]
10. Oxysterols and Oxysterol Sulfates in Alzheimer's Disease Brain and Cerebrospinal Fluid.
Dias IHK; Shokr H; Shephard F; Chakrabarti L
J Alzheimers Dis; 2022; 87(4):1527-1536. PubMed ID: 35491790
[TBL] [Abstract][Full Text] [Related]
11. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol Dysmetabolism in Alzheimer's Disease: A Starring Role for Astrocytes?
Staurenghi E; Giannelli S; Testa G; Sottero B; Leonarduzzi G; Gamba P
Antioxidants (Basel); 2021 Nov; 10(12):. PubMed ID: 34943002
[TBL] [Abstract][Full Text] [Related]
13. Oxidized cholesterol as the driving force behind the development of Alzheimer's disease.
Gamba P; Testa G; Gargiulo S; Staurenghi E; Poli G; Leonarduzzi G
Front Aging Neurosci; 2015; 7():119. PubMed ID: 26150787
[TBL] [Abstract][Full Text] [Related]
14. Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation.
Testa G; Staurenghi E; Zerbinati C; Gargiulo S; Iuliano L; Giaccone G; Fantò F; Poli G; Leonarduzzi G; Gamba P
Redox Biol; 2016 Dec; 10():24-33. PubMed ID: 27687218
[TBL] [Abstract][Full Text] [Related]
15. Processing of endogenous AβPP in blood-brain barrier endothelial cells is modulated by liver-X receptor agonists and altered cellular cholesterol homeostasis.
Schweinzer C; Kober A; Lang I; Etschmaier K; Scholler M; Kresse A; Sattler W; Panzenboeck U
J Alzheimers Dis; 2011; 27(2):341-60. PubMed ID: 21811018
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases.
Vance JE
Dis Model Mech; 2012 Nov; 5(6):746-55. PubMed ID: 23065638
[TBL] [Abstract][Full Text] [Related]
17. Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1.
Hascalovici JR; Vaya J; Khatib S; Holcroft CA; Zukor H; Song W; Arvanitakis Z; Bennett DA; Schipper HM
J Neurochem; 2009 Aug; 110(4):1241-53. PubMed ID: 19522732
[TBL] [Abstract][Full Text] [Related]
18. The landscape of metabolic brain alterations in Alzheimer's disease.
Batra R; Arnold M; Wörheide MA; Allen M; Wang X; Blach C; Levey AI; Seyfried NT; Ertekin-Taner N; Bennett DA; Kastenmüller G; Kaddurah-Daouk RF; Krumsiek J;
Alzheimers Dement; 2022 Jul; ():. PubMed ID: 35829654
[TBL] [Abstract][Full Text] [Related]
19. RNA-Sequencing Reveals Similarities and Differences in Gene Expression in Vulnerable Brain Tissues of Alzheimer's and Parkinson's Diseases.
Bennett JP; Keeney PM
J Alzheimers Dis Rep; 2018 Jul; 2(1):129-137. PubMed ID: 30480256
[TBL] [Abstract][Full Text] [Related]
20. Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer's disease brain proteomic signature.
Roberts JA; Varma VR; Candia J; Tanaka T; Ferrucci L; Bennett DA; Thambisetty M
NPJ Aging; 2023 Jul; 9(1):18. PubMed ID: 37414805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
